Zobrazeno 1 - 10
of 484
pro vyhledávání: '"de Roquancourt A"'
Autor:
Frank, Sophie, Dupont, Axelle, Teixeira, Luis, Porcher, Raphaël, De Roquancourt, Anne, Giacchetti, Sylvie, Espié, Marc, Cuvier, Caroline
Publikováno v:
In The Breast February 2016 25:51-56
Autor:
Bertheau, Philippe, Lehmann-Che, Jacqueline, Varna, Mariana, Dumay, Anne, Poirot, Brigitte, Porcher, Raphaël, Turpin, Elisabeth, Plassa, Louis-François, de Roquancourt, Anne, Bourstyn, Edwige, de Cremoux, Patricia, Janin, Anne, Giacchetti, Sylvie, Espié, Marc, de Thé, Hugues
Publikováno v:
In The Breast 1 August 2013 22 Supplement 2:S27-S29
Autor:
Goasguen, Nicolas, Chirica, Mircea, Roger, Natacha, Munoz-Bongrand, Nicolas, Zohar, Sarah, Noullet, Severine, de Roquancourt, Anne, Cattan, Pierre, Sarfati, Emile
Publikováno v:
In Journal of the American College of Surgeons 2010 210(4):456-462
Autor:
Florence Ledoux, A de Roquancourt, Stéphanie Bécourt, Paul Blanc-Durand, A. Binasker, Luca Campedel, Caroline Cuvier, Sylvie Giacchetti, L. Teixeira, Marc Espié, C Gardnair
Publikováno v:
Cancer Research. 79:P5-17
Background Inflammatory breast cancers (IBC) particularly triple negative (TN) subtype have poor prognosis. There are few series reporting IBC outcome according to their immunohistochemical profile. We have already shown the efficiency of dose dense
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db269ffd6f058bafb3e8b17b82b54f9e
https://doi.org/10.1158/1538-7445.sabcs18-p5-17-05
https://doi.org/10.1158/1538-7445.sabcs18-p5-17-05
Autor:
Philippe Bertheau, Charlotte Gardair, Laurence Cahen-Doidy, Patrick Charveriat, Philippe Drabent, Anne de Roquancourt
Publikováno v:
Annales de Pathologie
Annales de Pathologie, Elsevier Masson, 2019, 39, pp.9-13. ⟨10.1016/j.annpat.2018.07.004⟩
Annales de Pathologie, Elsevier Masson, 2019, 39, pp.9-13. ⟨10.1016/j.annpat.2018.07.004⟩
Resume La reconnaissance des metastases mammaires par le pathologiste est fondamentale car leur pronostic et leur traitement sont differents de ceux des carcinomes mammaires primitifs. Nous rapportons l’observation d’une patiente de 54 ans presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dceb05eaa4252548c3bd192f6134e888
https://doi.org/10.1016/j.annpat.2018.07.004
https://doi.org/10.1016/j.annpat.2018.07.004
Publikováno v:
Analytical Cellular Pathology, Vol 20, Iss 2-3, Pp 83-91 (2000)
Tumour progression is currently believed to result from genetic instability. Chromosomal patterns specific of a type of cancer are frequent even though phenotypic spatial heterogeneity is omnipresent. The latter is the usual cause of histological gra
Externí odkaz:
https://doaj.org/article/e8e4043d10a84e8786d215e477f68498
Autor:
Anne-Sophie Hamy, Amyn Kassara, Hamid Hocini, Clementine Garin, Luis Teixeira, Caroline Cuvier, Paul Gougis, Elise Dumas, Fabien Reyal, Beatriz Grandal, Nadir Sella, Eric Daoud, Aurélien Latouche, Thierry Dubois, Annabelle Ballesta, Samar Alsafadi, Elaine Del Nery, Élodie Anthony, Benjamin Marande, Cedric de Bazelaire, Anne de Roquancourt, Catherine Michel, Sylvie Giacchetti, Marc Espie
Publikováno v:
Cancer Research. 82:3348-3348
Context: There is a growing interest in drug repurposing and pathological complete response (pCR) that may influence the progression and treatment of breast cancer (BC). However, few studies focus on the influence of comedications, i.e., non-anticanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cce892b28390a8808c75cb2ed0ded256
https://doi.org/10.1158/1538-7445.am2022-3348
https://doi.org/10.1158/1538-7445.am2022-3348
Autor:
Stéphanie Bécourt, Florence Ledoux, Patrick Charveriat, Paul Blanc-Durand, Luis Augusto Teixeira, Jacqueline Lehmann-Che, E. Bourstyn, Sophie Guillerm, Cédric de Bazelaire, Luca Campedel, Anne de Roquancourt, Catherine Miquel, Caroline Cuvier, Sylvie Giacchetti, H. Hocini, Anne-Sophie Hamy, M. Espie, Asker Bin Asker
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (9), pp.2657. ⟨10.3390/cancers12092657⟩
Cancers, Vol 12, Iss 2657, p 2657 (2020)
Volume 12
Issue 9
Cancers, MDPI, 2020, 12 (9), pp.2657. ⟨10.3390/cancers12092657⟩
Cancers, Vol 12, Iss 2657, p 2657 (2020)
Volume 12
Issue 9
Inflammatory breast cancers are very aggressive, and among them, triple negative breast cancer (TNBC) has the worst prognosis. While many studies have investigated the association between tumor-infiltrating lymphocytes (TIL) before neoadjuvant chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67144cde11a07fc6652c48f0431a2a9
https://hal.sorbonne-universite.fr/hal-02953932
https://hal.sorbonne-universite.fr/hal-02953932
Autor:
Sylvie Giacchetti, Lilith Faucheux, Charlotte Gardair, Caroline Cuvier, Anne de Roquancourt, Luca Campedel, David Groheux, Cedric de Bazelaire, Jacqueline Lehmann-Che, Catherine Miquel, Laurence Cahen Doidy, Malika Amellou, Isabelle Madelaine, Fabien Reyal, Laetitia Someil, Hamid Hocini, Christophe Hennequin, Luis Teixeira, Marc Espié, Sylvie Chevret, Vassili Soumelis, Anne-Sophie Hamy
Publikováno v:
Cancers; Volume 14; Issue 5; Pages: 1331
Background: Patients with triple-negative breast cancers (TNBC) have a poor prognosis unless a pathological complete response (pCR) is achieved after neoadjuvant chemotherapy (NAC). Few studies have analyzed changes in TIL levels following dose-dense
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c34db4e21e2d94c24b11198f7b28e03
https://doi.org/10.3390/cancers14051331
https://doi.org/10.3390/cancers14051331
Publikováno v:
In Gynécologie Obstétrique & Fertilité 2006 34(1):3-7